LELYSTAD, The Netherlands, February 8, 2012 /PRNewswire/ -- Pepscan Therapeutics B.V., the Netherlands based biotechnology firm focusing on protein mimicry technology for the generation of novel therapeutics, today announced that it has achieved two milestones in the Research...

ROTTERDAM, The Netherlands and GHENT, Belgium, February 8, 2012 /PRNewswire/ -- ARGX-111IS AN ANTI-C-MET ANTIBODY WITH BROAD APPLICABILITY IN CANCER arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE...

Between the free-expression camp and the hard-line regimes with strict censorship policies are a host of important, growing nations that are just beginning to delve into the work of crafting Internet policy. And those countries could hold the key.

LELYSTAD, The Netherlands, February 8, 2012 /PRNewswire/ -- Pepscan Therapeutics B.V., the Netherlands based biotechnology firm focusing on protein mimicry technology for the generation of novel therapeutics, today announced that it has achieved two milestones in the Research...

ROTTERDAM, The Netherlands and GHENT, Belgium, February 8, 2012 /PRNewswire/ -- ARGX-111IS AN ANTI-C-MET ANTIBODY WITH BROAD APPLICABILITY IN CANCER arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE...

Between the free-expression camp and the hard-line regimes with strict censorship policies are a host of important, growing nations that are just beginning to delve into the work of crafting Internet policy. And those countries could hold the key.